CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 40 of 48

Rheumatology (Oxford)

Briefs 1,561–1,600 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Clusters based on demography, disease phenotype, and autoantibody status predicts mortality in lupus: data from Indian lupus cohort (INSPIRE)

    Cohort studyLupus & APS

  2. Rheumatology (Oxford)

    Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis

    Diagnostic or prognostic studyVasculitis & PMR

  3. Rheumatology (Oxford)

    New bone formation at the sacroiliac joint in axial spondyloarthritis: characterization of backfill in MRI and CT

    Mechanistic studySpondyloarthritis & PsA

  4. Rheumatology (Oxford)

    COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project

    Cohort studyAcross diseases

  5. Rheumatology (Oxford)

    Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis

    Cohort studyRA

  6. Rheumatology (Oxford)

    Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature

    Cohort studyMyositis

  7. Rheumatology (Oxford)

    Paediatric rheumatologists do not score the physician’s global assessment of juvenile idiopathic arthritis disease activity in the same way

    Cross-sectional studyPediatric

  8. Rheumatology (Oxford)

    Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis

    Case-control studyVasculitis & PMR

  9. Rheumatology (Oxford)

    Increased risk for stroke in patients with familial Mediterranean fever: results from a large population-based study

    Cohort studyAutoinflammatory & rare

  10. Rheumatology (Oxford)

    Unpublished clinical trials of common rheumatic diseases

    Cross-sectional studyAcross diseases

  11. Rheumatology (Oxford)

    Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys

    Research articleAcross diseases

  12. Rheumatology (Oxford)

    Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital

    Cross-sectional studyRA

  13. Rheumatology (Oxford)

    Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever

    Cohort studyPediatric

  14. Rheumatology (Oxford)

    Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study

    Cohort studyVasculitis & PMR

  15. Rheumatology (Oxford)

    Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State

    Secondary analysisLupus & APS

  16. Rheumatology (Oxford)

    E-learning and practical performance in musculoskeletal ultrasound: a multicentre randomized study

    Randomized controlled trial

  17. Rheumatology (Oxford)

    Metabolic and inflammatory profiles define phenotypes with clinical relevance in female knee osteoarthritis patients with joint effusion

    Cross-sectional studyOsteoarthritis

  18. Rheumatology (Oxford)

    Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes

    Cross-sectional studyLupus & APS

  19. Rheumatology (Oxford)

    Course and predictors of work productivity in gout — results from the NOR-Gout longitudinal 2-year treat-to-target study

    Cohort studyGout & crystals

  20. Rheumatology (Oxford)

    Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA

    Cohort studyRA

  21. Rheumatology (Oxford)

    Prevalence and clinical associations of ultrasound-confirmed enthesitis in systemic lupus erythematosus

    Cohort studyLupus & APS

  22. Rheumatology (Oxford)

    Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profiles

    Guideline or statementPediatric

  23. Rheumatology (Oxford)

    Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles

    Diagnostic or prognostic studyMyositis

  24. Rheumatology (Oxford)

    Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications

    Cohort studyMyositis

  25. Rheumatology (Oxford)

    Mortality estimates and excess mortality in rheumatoid arthritis

    Cohort studyRA

  26. Rheumatology (Oxford)

    Efficacy and safety of golimumab in patients with non-radiographic axial spondyloarthritis: a withdrawal and retreatment study (GO-BACK)

    Randomized controlled trialSpondyloarthritis & PsA

  27. Rheumatology (Oxford)

    The diagnostic value of urinary N-terminal fragment of titin for skeletal muscle damage in idiopathic inflammatory myopathy

    Diagnostic or prognostic studyMyositis

  28. Rheumatology (Oxford)

    TWEAK and Fn14 are overexpressed in immune-mediated necrotizing myopathy: implications for muscle damage and repair

    Mechanistic studyMyositis

  29. Rheumatology (Oxford)

    Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus

    Cohort studyLupus & APS

  30. Rheumatology (Oxford)

    IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis

    Mechanistic studyMyositis

  31. Rheumatology (Oxford)

    High-sensitivity cardiac troponin T in infants exposed to anti-Ro antibodies

    Cohort studyPediatric

  32. Rheumatology (Oxford)

    10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry

    Cohort studyAcross diseases

  33. Rheumatology (Oxford)

    Association between triglyceride-glucose index and carotid atherosclerosis in patients with psoriatic arthritis

    Cross-sectional studySpondyloarthritis & PsA

  34. Rheumatology (Oxford)

    Identification of new candidate drugs for primary Sjögren’s syndrome using a drug repurposing transcriptomic approach

    Cohort studySjögren's & overlap

  35. Rheumatology (Oxford)

    When it looks like Behçet’s syndrome but is something else: differential diagnosis of Behçet’s syndrome: a two-centre retrospective analysis

    Cohort studyVasculitis & PMR

  36. Rheumatology (Oxford)

    A randomized, double-blind, placebo-controlled, parallel group study on the effects of a cathepsin S inhibitor in primary Sjögren’s syndrome

    Randomized controlled trialSjögren's & overlap

  37. Rheumatology (Oxford)

    Reduced homovanillic acid, SDF-1α and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus

    Cohort studyLupus & APS

  38. Rheumatology (Oxford)

    Induction failure in granulomatosis with polyangiitis: a nationwide case-control study of risk factors and outcomes

    Case-control studyVasculitis & PMR

  39. Rheumatology (Oxford)

    Predictors of flare in SLE patients fulfilling lupus low disease activity state: a cohort study of 292 patients with 36-month follow-up

    Cohort studyLupus & APS

  40. Rheumatology (Oxford)

    Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure

    Research articleAcross diseases

All 1,905 Briefs in ExploreShowing Briefs 1,561–1,600 of 1,905, newest first